Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21
Eleni M. Domouzoglou, Katerina Κ. Naka, Antonios P. Vlahos, et al.
AJP Heart and Circulatory Physiology (2015) Vol. 309, Iss. 6, pp. H1029-H1038
Open Access | Times Cited: 106

Showing 1-25 of 106 citing articles:

Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease
Alan Chait, Laura J. den Hartigh
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 1037
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
Sven Francque, Denise van der Graaff, Wilhelmus J. Kwanten
Journal of Hepatology (2016) Vol. 65, Iss. 2, pp. 425-443
Open Access | Times Cited: 483
Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
Ana L. Cardoso, Adelaide Fernandes, Juan Antonio Aguilar‐Pimentel, et al.
Ageing Research Reviews (2018) Vol. 47, pp. 214-277
Open Access | Times Cited: 396
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Jing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Immunology (2023) Vol. 24, Iss. 9, pp. 1540-1551
Open Access | Times Cited: 356
New developments in the biology of fibroblast growth factors
David M. Ornitz, Nobuyuki Itoh
WIREs Mechanisms of Disease (2022) Vol. 14, Iss. 4
Open Access | Times Cited: 96
Roles of FGF Signals in Heart Development, Health, and Disease
Nobuyuki Itoh, Hiroya Ohta, Yoshiaki Nakayama, et al.
Frontiers in Cell and Developmental Biology (2016) Vol. 4
Open Access | Times Cited: 145
The Role of Osteoprotegerin and Its Ligands in Vascular Function
Luc Rochette, Alexandre Méloux, Eve Rigal, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 3, pp. 705-705
Open Access | Times Cited: 124
Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses
Antero Salminen, Kai Kaarniranta, Anu Kauppinen
Ageing Research Reviews (2017) Vol. 37, pp. 79-93
Closed Access | Times Cited: 105
Hepatic regulation of VLDL receptor by PPARβ/δ and FGF21 modulates non-alcoholic fatty liver disease
Mohammad Zarei, Emma Barroso, Xavier Palomer, et al.
Molecular Metabolism (2017) Vol. 8, pp. 117-131
Open Access | Times Cited: 96
Comparison of the Interactions of Different Growth Factors and Glycosaminoglycans
Fuming Zhang, Lanhong Zheng, Shuihong Cheng, et al.
Molecules (2019) Vol. 24, Iss. 18, pp. 3360-3360
Open Access | Times Cited: 78
Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis
Sarah Anthony, Adrienne Guarnieri, Anamarie Gozdiff, et al.
Clinical Science (2019) Vol. 133, Iss. 22, pp. 2329-2344
Open Access | Times Cited: 66
An Overview of FGF19 and FGF21: The Therapeutic Role in the Treatment of the Metabolic Disorders and Obesity
Nasim Babaknejad, Hashem Nayeri, Roohullah Hemmati, et al.
Hormone and Metabolic Research (2018) Vol. 50, Iss. 06, pp. 441-452
Closed Access | Times Cited: 65
The role of fibroblast growth factor 21 in atherosclerosis
John Kokkinos, Shudi Tang, Kerry‐Anne Rye, et al.
Atherosclerosis (2016) Vol. 257, pp. 259-265
Closed Access | Times Cited: 63
Effects of Oxidative Stress on Protein Translation: Implications for Cardiovascular Diseases
Arnab Ghosh, Natalia Shcherbik
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 8, pp. 2661-2661
Open Access | Times Cited: 57
Pegbelfermin (BMS-986036): an investigational PEGylated fibroblast growth factor 21 analogue for the treatment of nonalcoholic steatohepatitis
Cristy R.C. Verzijl, Ivo P. van de Peppel, Dicky Struik, et al.
Expert Opinion on Investigational Drugs (2020) Vol. 29, Iss. 2, pp. 125-133
Open Access | Times Cited: 52
Aerobic exercise regulates FGF21 and NLRP3 inflammasome-mediated pyroptosis and inhibits atherosclerosis in mice
Xiaohong Li, Liang-Zhong Liu, Lin Chen, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273527-e0273527
Open Access | Times Cited: 31
Therapeutic angiogenesis and tissue revascularization in ischemic vascular disease
Xinyue Chen, Wenlu Yu, Jing Zhang, et al.
Journal of Biological Engineering (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 20
Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction
Elsa Valdés‐Márquez, Robert Clarke, Michael Hill, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 7, pp. 583-591
Open Access | Times Cited: 18
Macronutrient Intake–Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial
Yoriko Heianza, Wenjie Ma, Tao Huang, et al.
Diabetes Care (2016) Vol. 39, Iss. 11, pp. 1909-1914
Open Access | Times Cited: 55
Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
Dicky Struik, Marleen B. Dommerholt, Johan W. Jonker
Current Opinion in Lipidology (2019) Vol. 30, Iss. 3, pp. 235-243
Open Access | Times Cited: 51
Inhibition of vascular neointima hyperplasia by FGF21 associated with FGFR1/Syk/NLRP3 inflammasome pathway in diabetic mice
Wei Wei, Xiao-Xue Li, Ming Xu
Atherosclerosis (2019) Vol. 289, pp. 132-142
Closed Access | Times Cited: 47
Fibroblast growth factor 21 enhances angiogenesis and wound healing of human brain microvascular endothelial cells by activating PPARγ
Wenting Huang, Mingjie Shao, Huan Liu, et al.
Journal of Pharmacological Sciences (2019) Vol. 140, Iss. 2, pp. 120-127
Open Access | Times Cited: 43
Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
Mieczysław Dutka, Rafał Bobiński, Wojciech Wojakowski, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 4, pp. 1395-1411
Open Access | Times Cited: 37
Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets
Jing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1960-1960
Open Access | Times Cited: 14
Fibroblast Growth Factor 21 Attenuates Vascular Calcification by Alleviating Endoplasmic Reticulum Stress Mediated Apoptosis in Rats
Yuchen Shi, Shaoping Wang, Hongyu Peng, et al.
International Journal of Biological Sciences (2018) Vol. 15, Iss. 1, pp. 138-147
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top